SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdex Bio Ord Regulatory News (0MTP)

Share Price Information for Idex Bio Ord (0MTP)

Share Price is delayed by 15 minutes
Get Live Data
7.14    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
0MTP Live PriceLast checked at - London Stock Exchange

Intraday Idex Bio Ord Share Chart

  • This share is an international stock.

IDEX delivers continued operational progress and strengthened commercial momentum

3 Mar 2026 07:57

IDEX Biometrics enters 2026 with validated products, increasing commercial traction, and a cost structure aligned with its product-company strategy.

Against the backdrop of a challenging geopolitical environment and the rising risk of AI-driven attacks, IDEX's products are more relevant than ever.

Authentication needs a reset to address the rapid evolution of AI-enabled threats, and IDEX provides the market's most secure authentication solution for physical and digital access — with biometric data processed and stored offline on the card. As AI-enabled threats scale, the case for hardware-rooted biometric authentication only strengthens. IDEX products are designed in such a way that it makes the customer compliant with evolving regulatory frameworks (NIS2, DORA and GDPR).

We are entering 2026 with a product offering vault-level security, lightning-fast authentication, broad compatibility, and simple deployment — and we are seeing clear proof points of product-market fit and growing commercial traction, supported by regulatory tailwinds," says CEO Anders Storbråten.

Certification timing affected Q4 revenues; strategy execution continuedQ4 was a quarter of continued execution of IDEX's product strategy. As the important product certifications, including FIDO 2 certification, were deferred into 2026. As a result, our fifth objective, Sales, was only partially achieved, reaching approximately 25% of target (received orders vs. normalised OpEx) As previously communicated, revenue is a lagging indicator. The leading indicators are — certification progress, customer validation, regulatory approvals, and order pipeline development. IDEX can confirm it is engaged with both public and private sector for our Access cards. The commercial traction has increased substantially during Q4 particularly after our presence at Trustech in Paris at the beginning of December.Operating expenses excluding Cost of Materials and Depreciation were $1.9 million in the fourth quarter of 2025, down 41% compared to $3.3 million in the fourth quarter of 2024.

We have continued to optimize our costs. Operating expenses, excluding restructuring charges, reached $8.5 million for the full year 2025, down 54% compared to $18.5 million in 2024.

Commercial traction and new Chief Revenue Officer in placeSince Q4 closing of the books, IDEX has seen continued positive development.FIDO certification has been in place since February 2026, and the company is progressing its commercial sales pipeline. IDEX has signed its first paid contract with a government entity operating under particularly high security and quality standards demonstrating the strength of IDEX product offering. The contract represents an important milestone and is expected to support further scaling of the Company's commercial footprint within high-security markets

IDEX's sales pipeline includes several prospective customers at various stages of engagement, representing both meaningful volume potential and customers of strong strategic and quality value.

As of 23 February 2026, IDEX has appointed Thomas Ludvik Næss as Chief Revenue Officer."I have been seeking the right profile to lead our next phase of commercial scaling and to execute on our ambitious sales targets. With more than 20 years of experience in cybersecurity and commercial expansion of security technologies, Thomas will lead and strengthen IDEX's commercial execution capabilities as we move from customer validation to broader market deployment. I am confident he will bring execution power to the company. Looking ahead, our certified product and growing commercial pipeline give me confidence that 2026 will be the year IDEX converts its current momentum into sustainable growth" says CEO Anders Storbråten.For further information, please contactAnders Storbråten, CEO and CFO, Mobile: +47 416 38 582Kjell-Arne Besseberg, COO. Mobile: +47 970 54 626E-mail: ir@idexbiometrics.com

About UsIDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.

IDEX Biometrics is advancing the future of access and payments with identity-first biometrics. With over a decade of proprietary innovation, our solutions are proven in the field, globally certified, and trusted by leading financial institutions. We serve enterprises, the public sector, banks, and issuers directly and through partners, delivering secure, seamless experiences in digital and physical access and payments. For more information, visit www.idexbiometrics.com

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-03 08:57 CET.

AttachmentsIDEX Q4 2025 Report Pub

Date   Source Headline
4th Jun 202610:00 amMFNIDEX Biometrics: IDEX Biometrics ASA: Registration of share capital increase
3rd Jun 20266:00 amMFNIDEX Biometrics: IDEX Biometrics ASA: Mandatory notification of trade and disclosure of large shareholding
1st Jun 20266:05 amMFNIDEX Biometrics: IDEX Biometrics ASA: Appoints new Executive Chairman and CEO
29th May 20264:30 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Annual general meeting held
29th May 20266:12 amMFNIDEX Biometrics: IDEX Biometrics ASA: Cancellation of the Subsequent Offering
29th May 20266:10 amMFNIDEX Biometrics: IDEX Biometrics ASA: Completed Private Placement
29th May 20266:00 amMFNIDEX Biometrics: IDEX Biometrics ASA. Q1 2026 results: Record order backlog and accelerating commercial activity
12th May 202611:55 amMFNIDEX Biometrics: IDEX Biometrics ASA: Registration of share capital increase
8th May 20262:45 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Notice of annual general meeting on May 29, 2026
7th May 20269:20 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Resolution to carry out Tranche 2 of the Private Placement
6th May 20268:40 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Mandatory notification of trade and disclosure of large shareholding
6th May 20268:30 amMFNIDEX Biometrics: IDEX Biometrics ASA: Registration of share capital increase
30th Apr 20266:55 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Annual report 2025
29th Apr 20269:15 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Issuance of consultant shares
29th Apr 20265:55 amMFNIDEX Biometrics: IDEX Biometrics ASA: Ex. potential subsequent offering
29th Apr 20265:48 amMFNIDEX Biometrics: Mandatory notification of trade and disclosure of large shareholding
29th Apr 202612:30 amMFNIDEX Biometrics: IDEX Biometrics ASA: Key information regarding potential subsequent offering
28th Apr 202611:55 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Private Placement successfully placed
28th Apr 20262:34 pmMFNIDEX Biometrics: IDEX Biometrics ASA: Contemplated Private Placement
27th Mar 20261:15 pmMFNIDEX Biometrics ASA: Extraordinary general meeting held on 27 March 2026
24th Mar 20269:15 pmMFNDisclosure of voting rights in IDEX Biometrics to CEO Anders Storbråten
5th Mar 20268:43 pmMFNIDEX Biometrics secures NOK 90 million in private placement and exclusive technology partnership with Leading APAC Biometric ID Solutions Provider
3rd Mar 20267:57 amMFNIDEX delivers continued operational progress and strengthened commercial momentum
3rd Mar 20267:57 amMFNIDEX delivers continued operational progress and strengthened commercial momentum
26th Feb 20266:30 amMFNGrant of incentive subscription rights in IDEX Biometrics
30th Jan 20262:45 pmMFNIDEX Biometrics ASA: Registration of share capital increase
26th Jan 20267:00 pmMFNMandatory notice of shareholding
26th Jan 20266:30 pmMFNMandatory disclosure of trade by primary insiders or close associates in IDEX Biometrics
20th Jan 20262:45 pmMFNIDEX Biometrics ASA: Extraordinary general meeting held on 20 January 2026
14th Jan 20269:40 amMFNIDEX Biometrics ASA: Registration of share capital increase
12th Jan 20266:00 amMFNIDEX Biometrics ASA: Conversion of bonds and share capital increase
15th Dec 202511:51 amMFNIDEX Biometrics ASA: Registration of share capital increase
8th Dec 202510:30 pmMFNMandatory disclosure of trade by primary insiders or close associates in IDEX Biometrics
4th Dec 202511:40 pmMFNIDEX Biometrics ASA - Private Placement successfully placed
4th Dec 20254:11 pmMFNIDEX Biometrics ASA - Contemplated Private Placement
13th Nov 20256:31 amMFNIDEX Biometrics ASA: Third Quarter 2025 Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.